ProMIS Neurosciences
PMN
23 hedge funds and large institutions have $4.25M invested in ProMIS Neurosciences in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
21% more funds holding
Funds holding: 19 → 23 (+4)
4% more capital invested
Capital invested by funds: $4.1M → $4.25M (+$146K)
0.27% less ownership
Funds ownership: 1.04% → 0.77% (-0.27%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ABG
Ally Bridge Group
New York
|
+$2.71M |
| 2 |
AC
Armistice Capital
New York
|
+$463K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$59.1K |
| 4 |
HF
HRT Financial
New York
|
+$37.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$37.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$1.28M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$888K |
| 3 |
KWM
Kingsview Wealth Management
Grants Pass,
Oregon
|
-$15K |
PMN Hedge Fund Activity: Q3 2025 in Review
23 of the 7,629 institutional investors tracked by Wall St. Rank reported a position in ProMIS Neurosciences (PMN) for Q3 2025, worth a combined $4.25M — up 3.6% from $4.1M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new PMN positions and 3 closed out — a net gain of 5 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Ally Bridge Group, adding an estimated $2.71M. The largest seller was Great Point Partners, exiting entirely with an estimated $1.28M sold.
- 23 institutional investors held ProMIS Neurosciences (PMN) as of Q3 2025, up from 19 in Q2 2025.
- Funds reported $4.25M of ProMIS Neurosciences stock for Q3 2025, up 3.6% quarter-over-quarter.
- 8 funds opened new ProMIS Neurosciences positions in Q3 2025 and 3 closed out, a net change of +5 holders.
- The largest ProMIS Neurosciences buyer in Q3 2025 was Ally Bridge Group, an estimated $2.71M added.
- The largest ProMIS Neurosciences seller in Q3 2025 was Great Point Partners, an estimated $1.28M sold.
Based on aggregated 13F filings for Q3 2025.